TabsDetailsBasic DetailsDate Posted: Thursday, August 22, 2019Status: CompleteMedical Product: angiotensin receptor blocker, angiotensin-converting enzyme (ACE) inhibitorDescription: The goal of this request was to estimate the number of prevalent users and dispensings of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) among pediatric populations in the Sentinel Distributed Database (SDD). Data from January 1, 2001 to December 31, 2012 from 15 Data Partners contributing to the SDD were included in this report. This request was distributed on July 1, 2016. Read More Deliverables (1)Sentinel Modular Program Report: Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) in a Pediatric PopulationAdditional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2001 - December 31, 2012Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: Children 1 to 72 months of ageData Sources: Sentinel Distributed Database (SDD)
